Medical device and MedTech insights, news, tips and more

First Medical Device Treatment for Childhood ADHD Cleared by FDA

April 22, 2019

neurosigma monarch

NeuroSigma won de novo clearance from the FDA last week to put the first medical device for treating attention-deficit hyperactivity disorder on the U.S. market.

Los Angeles-based NeuroSigma makes the Monarch eTNS system, which is designed to deliver mild electrical signals through a forehead patch to stimulate branches of the trigeminal nerve during sleep. The device won CE Mark approval in the European Union in November 2015 for treating ADHD in in adults and children age 7 and older.

The federal safety watchdog said it based the approval on a 62-patient study that compared four weeks of Monarch eTNS treatment with a sham device, with a primary endpoint of improvement on the ADHD-RS scale. Patients in the treatment arm showed statistically significant improvement compared with the placebo group, the FDA said, with ADHD-RS scores decreasing -31.4% from 34.1 points to 23.4 points; the sham control arm showed a decrease of -18.4%, from 33.7 to 27.5 points.

“This new device offers a safe, non-drug option for treatment of ADHD in pediatric patients through the use of mild nerve stimulation, a first of its kind,” CDRH neurological & physical medicine devices director Carlos Peña said in prepared remarks. “Today’s action reflects our deep commitment to working with device manufacturers to advance the development of pediatric medical devices so that children have access to innovative, safe and effective medical devices that meet their unique needs.”

Read Full Article at the Source: NeuroSigma wins FDA nod for ADHD device

Article Written by: Brad Perriello

A Speciality Recruiting Firm Exclusively Servicing The Medical Device Industry

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.